ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Parallel Works Achieves DoD IL5 ATO With InfusionPoints' FedRAMP High Security Expertise

NORTH WILKESBORO, NC / ACCESS Newswire / September 19, 2025 / Parallel Works has officially received its Authorization to Operate (ATO) for the ACTIVATE High Security Platform (HSP) at DoD Impact Level 5 (IL5), marking a major milestone in secure cloud computing for federal agencies. This achievement was made possible through a strategic partnership with InfusionPoints, a leader in cybersecurity and compliance services.Parallel Works Achieved DoD IL5 ATO

Parallel Works Achieved DoD IL5 ATO

InfusionPoints played a pivotal role in supporting Parallel Works through the DoD IL5 authorization process, implementing security controls aligned with both FedRAMP High and DoD CC SRG IL5 requirements. Leveraging InfusionPoints' XccelerATOr compliance automation platform and deep domain expertise, InfusionPoints accelerated the deployment of a fully compliant, mission-ready cloud environment on AWS GovCloud (US).

A Partnership Built for Speed, Security, and Scale

The collaboration between Parallel Works and InfusionPoints significantly reduced the time, complexity, and cost typically associated with DISA cloud security authorizations. InfusionPoints provided:

  • Security Architecture & Control Implementation: based on FedRAMP High and IL5 baselines

  • Infrastructure-as-Code (IaC): hardened landing zones

  • Continuous Monitoring & Managed Security Services:

    • FedRAMP ConMon

    • MDR/XDR

    • Threat Hunting

    • Vulnerability Management

    • Static & Dynamic Code Analysis

This comprehensive support ensured that Parallel Works could meet the stringent requirements for hosting Controlled Unclassified Information (CUI) and other sensitive workloads in a secure, compliant cloud environment.

Accelerated ATO, Reduced Costs, and Product-Centric Focus

InfusionPoints' support enabled Parallel Works to achieve ATO faster and more cost effectively by offloading the complexity of compliance and implementation. Instead of diverting internal resources to navigate the intricate IL5 framework, Parallel Works was able to focus on building and refining their ACTIVATE platform, confident that InfusionPoints was handling the security and compliance roadmap.

This strategic approach not only reduced the total cost of ownership for Parallel Works' IL5 environment but also shortened the path to ATO, allowing them to bring their secure cloud platform to market faster.

ACTIVATE High Security Platform: Mission-Ready and Future-Proof

Parallel Works' ACTIVATE HSP is a hybrid multi-cloud computing control plane designed to meet the evolving needs of DoD and federal agencies. ACTIVATE is fully equipped to support secure digital transformation across federal environments.

Key features include:

  • Secure Cloud Infrastructure tailored for U.S. government data residency

  • Rapid Compliance Deployment for IL5 workloads

  • Scalable Solutions that evolve with mission requirements

About Parallel Works

Parallel Works ACTIVATE is a leading hybrid multi-cloud computing control plane, empowering teams with seamless provisioning, management, and sharing of compute resources at scale across on-premises and cloud environments with advanced cost control and budgeting features. ACTIVATE facilitates collaborative research and enhances productivity through intuitive interfaces and API-driven processes, enabling the operating system for complex enterprise computing environments. Visit Parallel Works at parallelworks.com.

About InfusionPoints

InfusionPoints is a HUBZone Small Business with ISO 9001:2015, ISO 27001:2022, and ISO 17020 certifications, and is accredited by A2LA as a FedRAMP 3PAO, helping customers Build, Manage, and Defend their cloud solutions.

Contact Information

Felisha Daemer
VP of Public Sector
felisha.daemer@infusionpoints.com
3369900252

SOURCE: InfusionPoints, LLC

SOURCE: InfusionPoints, LLC



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.